Kayser, S
Benner, A
Thiede, C
Martens, U
Huber, J
Stadtherr, P
Janssen, J W G
Röllig, C
Uppenkamp, M J
Bochtler, T
Hegenbart, U
Ehninger, G
Ho, A D
Dreger, P
Krämer, A
Article History
Received: 1 May 2016
Accepted: 19 May 2016
First Online: 29 July 2016
Competing interests
: PD has received research support from Riemser Pharma and Neovii, and has worked as consultant for Riemser Pharma. UH has received honoraria from Janssen. AK has received research support from Merck and Bayer. SK gratefully acknowledges to have received a grant from the University of Heidelberg. CT is part owner of AgenDix GmbH. All other authors declare no competing conflict of interest.